麗珠集團(000513.SZ)收漲7.42%逼近歷史最高價 正持續回購股份
格隆匯6月9日丨麗珠集團(000513.SZ)收漲7.42%報43.85元,盤中最高價為44.44元,逼近2018年1月創出的歷史最高價44.54元,成交9.92億元,最新總市值369億元。H股目前漲5.51%報33.5港元。麗珠集團曾於今年3月份公佈擬回購2.5億-5億元股份,回購價格不超過45元/股,回購股份期限為自股東大會審議通過回購股份方案之日起不超過9個月。截至5月31日已累計回購339.598萬股,耗資約1.36億元;據格隆匯統計,6月至今,該股再度進行了三次回購操作,累計回購121.38萬股,耗資4814.92萬元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.